Offering expertise on regulatory compliance, M&A deals in the life sciences space, sanctions and export controls, and the legal implications of clinical trials, Hogan Lovells International LLP provides a comprehensive service for clients in the Chinese market. The team is jointly led by Roy Zou, who is highly experienced in U.S. litigation matters involving Chinese companies or government agencies as respondents or defendants, and cross-border transactional and financing expert Lu Zhou. The regulatory compliance focussed Calvin Ding, who is experienced in both government sanctioned and internal compliance investigations, is also key, as is life sciences and healthcare sector antitrust expert Adrian Emch. Jessie Xie, who specialises in medical device and pharmaceutical clinical trials and product approval issues, is also well-recommended.

Legal 500 Editorial commentary

Key clients

  • Merck & Co. Inc.

Work highlights

  • Advising Merck & Co., Inc. in connection with cross border litigation concerning rights in the MERCK trademark and trade name.

Lawyers

Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Roy Zou, Lu Zhou

Other key lawyers

Calvin Ding, Adrian Emch, Jessie Xie